References:

  1. Guideline Subcommittee. 1999 World Heath Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertension 1999; 17:151-83
  2. Bernard Waeber. Achieving Blood pressure Targets in the Management of Hypertension Blood pressure 2001, 10 (Supple 2): 6-12.
  3. David J Hyman, Valory N. Pavalik. Characteristics of patients with uncontrolled hypertension in the United States. N Engle J Med 2001; 345; 479-86
  4. Mj Brown, CR Palmer, A Castaigne, P de Leeuw, T Rosenthal, LM Ruilope, G Mancia. International Nifedipine once-daily study: Intervention as a Goal Hypertension Treatment. Circulation 6/2001
  5. R B Singh. Hypertension and stroke in Asia. Internal Medicine Journal of Thailand Vol. 17 N 3 July- Sep 2001-7
  6. Lip Ping Low. Hypertension in the Asia -Pacific region: What we know, need to know and need to do. Internal Medicine Journal of Thailand. Vol. 17 N 3 July- Sep 2001-4
  7. Tran Do Trinh & cs. Dieu tra dich te hoc tang huyet ap o Viet Nam. Tim mach hoc 18 1999. 28-31
  8. Tran Van Huy va cs. Dieu tra dich te tang huyet ap tren toan tinh Khanh Hoa. Noi khoa 2 1990, 3-8
  9. Do Quoc Huong Pham Gia Khai va cs. Dac diem dich te hoc benh tang huyet ap tai Ha Noi, Tap chí tim mach hoc so 21/2000, 258-282
  10. Pham Gia Khai. Dieu tra dich te tang huyet ap tai Ha noi. Bao cao tai Viet nam congress of cardiology 4/2002
  11. Peera Buranakitjaroen. Epidemiology of hypertension in Thailand. Internal Medicine Journal of Thailand Vol. 17 N 3 July- Sep 2001-5
  12. Bang Hun Lee. Current status of hypertension in South Korea Internal Medicine Journal of Thailand Vol. 17 N 3 July- Sep 2001-7
  13. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expect Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III) JAMA 2001 285 2486-97
  14. Tran van Huy. The advances in cholesterol management from ATP III 5/2001. TMH. VN 7/2001.24-34
  15. American Diabetes Association. Clinical Practice Recommendations 2001. Diabetes Care 2001. 24 suppl. 17:s33-43
  16. The Sixth Report of the National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure NIH Publication No 98-4080 November 1997
  17. Ramsay LE et al. British Hypertension Society Guidelines for hypertension management 1999; summary, BMJ 1999;319;630-5
  18. Wood D et al. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the second joint Task Force of European and other societies on coronary Prevention. J Hypertens. 1998; 16;1407-14
  19. 2000 Canada recommendation for the management of Hypertension. Jan 18, 2000
  20. Scott M. Grundy et al. Assessment of cardiovascular risk by use of Multiple-Risk-factors assessment Equations. J Am cardio 1999; 34; 1348-59
  21. Sidney C et al. AHA/ACC Guidelines for Preventing Heart attack and Death in Patients with Atherosclerotic Cardiovascular Disease: 2001 update. Circulation 2001; 104;1577-1579
  22. Elliott H L., Connell JMC. The year in hypertension 2000. Recent trial results. Cl. Pub, ser, Oxford 2000,1-23
  23. Rutan GH et al. The Multiple Risk Factor Intervention Trial (MRFIT) Circulation 1998. 77:504-514
  24. J He, P K Whelton. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens. 1999; 17 (Suppl. 2); S7-S13
  25. J A Staessen, JG Wang, L Thijs, R Fagard. Overview of the outcome trials in older patients with isolated systolic hypertension. J Hum hypertens. 1999; 13:859-63
  26. Norman M. Kaplan. Systemic hypertension. Heart disease. Sixth edition 2001. 807- 862
  27. Sunil Das. Lessons Learned from Recent Clinical Trials. Report in the second Congress of Asian - Pacific Society of Hypertension 19-22 August 2001. Pattaya Thailand.
  28. Stuart J Pocok et al. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure. Based on individual patient data from randomized control trials BMJ Vol. 323 July 2001;75-81
  29. Barry Davis. Major Cardiovascular Events in Hypertensive Patients randomized to Doxazosin Vs Chlorthalidone. The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) JAMA April 19 2000 Vol. 283 No 15 1967-1975
  30. Collins R et al. The Heart Protective study. Presented at the American Heart Association Scientific Sessions. November 13, 2001
  31. Michael Weber, Giancarlo Viberti. Hypertension and microalbuminuria in type 2 diabetes: a review of recent published studies. 2001.
  32. V. H. Tran, M. Baudet, J. L. Roynard, B. Lahitton, P. Hericotte. Etude De Quelques Indices D'echocardiographie Chez Les Sujets Ages Hosptalises Au Centre Hospitalier De Dax En France
  33. Raj Padwal et al. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review. BMJ Vol. 322 22 April 2001;977-9
  34. John Chalmers Giueppe Mancia. Blood pressure burden: vascular changes and cerebrovascular complications. Vol. 18 Supple 1 May 2000.
  35. Kannayiram Algiakrishnan et al. Blood pressure dysregulation syndrome. The case for control throughout the circadian cycle Geriatric. March 2001 Vol. 56 N.3 50-61.
  36. Michael Pignone, Cynthia D Mulrow. Using cardiovascular risk profiles to individualize hypertensive treatment. BMJ Vol 322 12 May 2001; 1164-66
  37. Frederique Thomas et al. Cardiovascular Mortality in Hypertensive Men according to Presence of Associated Risk Factors. Hypertension 2001; 37:1256.
  38. Jan N BASILE. Hypertension 2001. How will JNC VII be different JNC VI? Southern Medical Journal Sept 2001, vol 94 no 9 889-90
  39. Amala A. Louis , I. Renata Manousos , Alison P. Coletta , Andrew L. Clark and John G.F. Cleland Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. European J Heart Failure. 2002 4 1 111-116